Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parker, W. D.
Right arrow Articles by Cullum, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parker, W. D., Jr.
Right arrow Articles by Cullum, C. M.
NEUROLOGY 1994;44:1086
© 1994 American Academy of Neurology

Reduced platelet cytochrome c oxidase activity in Alzheimer's disease

W. D. Parker, Jr., MD, N. J. Mahr, MS, C. M. Filley, MD, J. K. Parks, BA, D. Hughes, MA, D. A. Young, PhD and C. M. Cullum, PhD

Departments of Neurology (Drs. Parker, Filley, and Cullum, and N.J. Mahr and J.K. Parks), Pediatrics (Dr. Parker), Preventive Medicine and Biometrics (Dr. Young), and Psychiatry (Drs. Filley and Cullum, and D. Hughes), University of Colorado School of Medicine, Denver, CO.

We evaluated a simplified method for preparation and analysis of platelet cytochrome c oxidase activity in Alzheimer's disease (AD) and control patients. Mean cytochrome c oxidase activity in controls (n = 17) was 0.233 sec–1/mg whereas mean cytochrome c oxidase activity in Alzheimer patients (n = 19) was 0.193 sec–1/mg, p=0.033. Complex III (ubiquinol:cytochrome c oxidoreductase), complex II (succinic dehydrogenase), and citrate synthase were all assayed as internal controls and were not significantly different in controls and Alzheimer patients. There is a relatively specific loss of platelet cytochrome c oxidase activity in Alzheimer disease patients.

Address correspondence and reprint requests to Dr. W.D. Parker, Box 394, University of Virginia Medical Center, Charlottesville, VA 22908.

Supported by grant AG09417 from the National Institute on Aging.

Received August 13, 1993. Accepted for publication in final form November 24, 1993.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Fukui, F. Diaz, S. Garcia, and C. T. Moraes
Cytochrome c oxidase deficiency in neurons decreases both oxidative stress and amyloid formation in a mouse model of Alzheimer's disease
PNAS, August 28, 2007; 104(35): 14163 - 14168.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
N. Shinjyo and K. Kita
Up-Regulation of Heme Biosynthesis during Differentiation of Neuro2a Cells.
J. Biochem., March 1, 2006; 139(3): 373 - 381.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
U. Keil, A. Bonert, C. A. Marques, I. Scherping, J. Weyermann, J. B. Strosznajder, F. Muller-Spahn, C. Haass, C. Czech, L. Pradier, et al.
Amyloid {beta}-induced Changes in Nitric Oxide Production and Mitochondrial Activity Lead to Apoptosis
J. Biol. Chem., November 26, 2004; 279(48): 50310 - 50320.
[Abstract] [Full Text] [PDF]


Home page
AM J ALZHEIMERS DIS OTHER DEMENHome page
X. Zhu, M. A. Smith, G. Perry, and G. Aliev
Mitochondrial failures in Alzheimer's disease
American Journal of Alzheimer's Disease and Other Dementias, November 1, 2004; 19(6): 345 - 352.
[Abstract] [PDF]


Home page
J. Neurosci.Home page
J. Valla, J. D. Berndt, and F. Gonzalez-Lima
Energy Hypometabolism in Posterior Cingulate Cortex of Alzheimer's Patients: Superficial Laminar Cytochrome Oxidase Associated with Disease Duration
J. Neurosci., July 1, 2001; 21(13): 4923 - 4930.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
D. C. SOLANO, M. SIRONI, C. BONFINI, S. B. SOLERTE, S. GOVONI, and M. RACCHI
Insulin regulates soluble amyloid precursor protein release via phosphatidyl inositol 3 kinase-dependent pathway
FASEB J, May 1, 2000; 14(7): 1015 - 1022.
[Abstract] [Full Text]


Home page
Arch NeurolHome page
A. H. V. Schapira
Inborn and Induced Defects of Mitochondria
Arch Neurol, October 1, 1998; 55(10): 1293 - 1296.
[Full Text] [PDF]


Home page
Arch NeurolHome page
S. Sevush, W. Jy, L. L. Horstman, W.-W. Mao, L. Kolodny, and Y. S. Ahn
Platelet Activation in Alzheimer Disease
Arch Neurol, April 1, 1998; 55(4): 530 - 536.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. P. Sheehan, R. H. Swerdlow, S. W. Miller, R. E. Davis, J. K. Parks, W. D. Parker, and J. B. Tuttle
Calcium Homeostasis and Reactive Oxygen Species Production in Cells Transformed by Mitochondria from Individuals with Sporadic Alzheimer's Disease
J. Neurosci., June 15, 1997; 17(12): 4612 - 4622.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. E. Davis, S. Miller, C. Herrnstadt, S. S. Ghosh, E. Fahy, L. A. Shinobu, D. Galasko, L. J. Thal, M. F. Beal, N. Howell, et al.
Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease
PNAS, April 29, 1997; 94(9): 4526 - 4531.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by AAN Enterprises, Inc.